Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
March 12, 2026
Pasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of Directors
September 20, 2022
Related Post
-
-
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
March 12, 2026
-
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone
March 11, 2026
-
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
March 11, 2026